How many insider declarations has 5AM Ventures VI, L.P. filed?

5AM Ventures VI, L.P. has filed 3 public insider declarations with SEC (Form 4).

What is 5AM Ventures VI, L.P.'s role?

5AM Ventures VI, L.P.'s reported role is not specified by the regulator across the filings.

Which companies does 5AM Ventures VI, L.P. report trades for?

5AM Ventures VI, L.P. reports trades for 2 companies, including Vor Biopharma Inc..

What is 5AM Ventures VI, L.P.'s declared buy vs sell volume?

Across the available history, declared buys total 0 and disposals 3.2M€.

← Executives ★ Sign in to follow

5V

5AM Ventures VI, L.P.

Other

·SEC (Form 4)

Vor Biopharma Inc.Latigo Biotherapeutics, Inc.

0

申报总数

0

公司

—

▲ 买入（0 笔）

€322万

▼ 卖出（1 笔）

内部人交易记录

其他

已披露买入

0

已披露卖出

1

尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。

信号历史

无可用的信号评分。

Discover the detailed record of transactions filed by 5AM Ventures VI, L.P.. Director active across 2 companies, notably Vor Biopharma Inc.. Cumulatively, 3 disclosures have been recorded. Split: 0 buy · 1 sell. Total volume traded: €3.2m. History available since 16 November 2021. The latest transaction was disclosed on 16 November 2021 (Cession). Regulator: SEC (Form 4). All data is free.

Companies and markets linked to 5AM Ventures VI, L.P.

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Vor Biopharma Inc. (US)Latigo Biotherapeutics, Inc. (US)

申报3 总计

●

5AM Ventures VI, L.P.

10% Owner高管2026年8月10日Latigo Biotherapeutics, Inc.

0SEC ↗

4,975,543 股Common StockSEC:0001231919-26-000869:0

●

5AM Ventures VI, L.P.

10% Owner高管2026年8月10日Latigo Biotherapeutics, Inc.

0SEC ↗

2,350,419 股Common StockSEC:0001231919-26-000869:1

▼

5AM Ventures VI, L.P.

高管2021年11月16日Vor Biopharma Inc.

US$365万22SEC ↗

238,870 股@ US$15.30100.0% 占其流量Common StockSEC:0001209191-21-065661:0

3 条申报中的 3 条

InsidersTradesSigma

← Executives ★ Sign in to follow

5V

5AM Ventures VI, L.P.

Other

·SEC (Form 4)

Vor Biopharma Inc.Latigo Biotherapeutics, Inc.

0

申报总数

0

公司

—

▲ 买入（0 笔）

€322万

▼ 卖出（1 笔）

内部人交易记录

其他

已披露买入

0

已披露卖出

1

尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。

信号历史

无可用的信号评分。

Discover the detailed record of transactions filed by 5AM Ventures VI, L.P.. Director active across 2 companies, notably Vor Biopharma Inc.. Cumulatively, 3 disclosures have been recorded. Split: 0 buy · 1 sell. Total volume traded: €3.2m. History available since 16 November 2021. The latest transaction was disclosed on 16 November 2021 (Cession). Regulator: SEC (Form 4). All data is free.